{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:50:58Z","timestamp":1791337858221,"version":"4.3.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Suven Life Sciences Ltd"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejps.2020.105425","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T13:09:07Z","timestamp":1591794547000},"page":"105425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Absorption, distribution, metabolism, excretion (ADME), drug-drug interaction potential and prediction of human pharmacokinetics of SUVN-G3031, a novel histamine 3 receptor (H3R) inverse agonist in clinical development for the treatment of narcolepsy"],"prefix":"10.1016","volume":"152","author":[{"given":"Ramakrishna","family":"Nirogi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopinadh","family":"Bhyrapuneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nageswara Rao","family":"Muddana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunkumar","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Rasheed","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagasurya Prakash","family":"Padala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devender Reddy","family":"Ajjala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramkumar","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veera Raghava Chowdary","family":"Palacharla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejps.2020.105425_bib0001","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1124\/dmd.114.058834","article-title":"Expression of hepatic drug-metabolizing Cytochrome P450 enzymes and their intercorrelations: a meta-analysis","volume":"42","author":"Achour","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2020.105425_bib0002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/138920007779315053","article-title":"Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver","volume":"8","author":"Barter","year":"2007","journal-title":"Curr. Drug Metab."},{"issue":"8","key":"10.1016\/j.ejps.2020.105425_bib0003","first-page":"1399","article-title":"International consortium for innovation and quality in pharmaceutical development (IQ) victim drug-drug interactions working group","volume":"44","author":"Bohnert","year":"2016","journal-title":"Eval. New Mol. Entity Victim Metab. Drug-Drug Interact. Ind. Perspect. Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2020.105425_bib0004","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1124\/dmd.115.067769","article-title":"Grime K. determination of human hepatocyte intrinsic clearance for slowly metabolized compounds: comparison of a primary hepatocyte\/stromal cell co-culture with plated primary hepatocytes and HepaRG","volume":"44","author":"Bonn","year":"2016","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.ejps.2020.105425_bib0005","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1124\/dmd.115.067538","article-title":"Quantification of flavin-containing monooxygenase 1, 3, and 5 in human liver microsomes by UPLC-MRM-based targeted quantitative proteomics and its application to the study of ontogeny","volume":"44","author":"Chen","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2020.105425_bib0006","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1124\/dmd.110.032649","article-title":"Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data","volume":"38","author":"Gertz","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2020.105425_bib0007","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1124\/dmd.111.043984","article-title":"Characterization of in vitro glucuronidation clearance of a range of drugs in human kidney microsomes: comparison with liver and intestinal glucuronidation and impact of albumin","volume":"40","author":"Gill","year":"2012","journal-title":"Drug Metab. Dispos."},{"issue":"12","key":"10.1016\/j.ejps.2020.105425_bib0008","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1124\/dmd.115.066431","article-title":"Low-turnover drug molecules: a current challenge for drug metabolism scientists","volume":"43","author":"Hutzler","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2020.105425_bib0009","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1124\/dmd.113.051664","article-title":"Utility of in vitro systems and preclinical data for the prediction of human intestinal first-pass metabolism during drug discovery and preclinical development","volume":"41","author":"Karlsson","year":"2013","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.ejps.2020.105425_bib0010","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1097\/00000542-199912000-00032","article-title":"First-pass lung uptake and pulmonary clearance of propofol: assessment with a recirculatory indocyanine green pharmacokinetic model","volume":"91","author":"Kuipers","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejps.2020.105425_bib0011","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3109\/00498259609052491","article-title":"Interspecies scaling: predicting clearance of drugs in humans. Three different approaches","volume":"26","author":"Mahmood","year":"1996","journal-title":"Xenobiotica."},{"issue":"7","key":"10.1016\/j.ejps.2020.105425_bib0022","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s40261-020-00920-8","article-title":"Safety, Tolerability, and Pharmacokinetics of SUVN-G3031, a Novel Histamine-3 Receptor Inverse Agonist for the Treatment of Narcolepsy, in Healthy Human Subjects Following Single and Multiple Oral Doses","volume":"40","author":"Nirogi","year":"2020","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ejps.2020.105425_bib0012","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1021\/acs.jmedchem.8b01280","article-title":"Discovery and development of N-[4-(1-Cyclobutylpiperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acetamide Dihydrochloride (SUVN-G3031): a novel, potent, selective, and orally active histamine H3 receptor inverse agonist with robust wake-promoting activity","volume":"62","author":"Nirogi","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2020.105425_bib0014","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1124\/dmd.110.037267","article-title":"Prediction of human renal clearance from preclinical species for a diverse set of drugs that exhibit both active secretion and net reabsorption","volume":"39","author":"Paine","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2020.105425_bib0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/00498254.2018.1434913","article-title":"Methoxsalen as an in vitro phenotyping tool in comparison with 1-aminobenzotriazole","volume":"49","author":"Palacharla","year":"2018","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.ejps.2020.105425_bib0016","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sleep.2014.10.002","article-title":"Clinical and practical considerations in the pharmacologic management of narcolepsy","volume":"16","author":"Thorpy","year":"2015","journal-title":"Sleep Med."},{"key":"10.1016\/j.ejps.2020.105425_bib0017","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40263-019-00689-1","article-title":"Recently approved and upcoming treatments for narcolepsy","volume":"34","author":"Thorpy","year":"2020","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/j.ejps.2020.105425_bib0018","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1128\/AAC.00843-13","article-title":"CYP2J2 and CYP2C19 are the major enzymes responsible for metabolism of albendazole and febendazole in human liver microsomes and recombinant P450 assay systems","volume":"57","author":"Wu","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2020.105425_bib0019","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1124\/dmd.106.013359","article-title":"Misuse of the well-stirred model of hepatic drug clearance","volume":"35","author":"Yang","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2020.105425_bib0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/bdd.2068","article-title":"A comparative evaluation of models to predict human intestinal metabolism from nonclinical data","volume":"38","author":"Yau","year":"2017","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2020.105425_bib0021","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-5173(99)00147-7","article-title":"A compartmental absorption and transit model for estimating oral drug absorption","volume":"186","author":"Yu","year":"1999","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720302141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720302141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T01:26:25Z","timestamp":1776043585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098720302141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":21,"alternative-id":["S0928098720302141"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105425","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Absorption, distribution, metabolism, excretion (ADME), drug-drug interaction potential and prediction of human pharmacokinetics of SUVN-G3031, a novel histamine 3 receptor (H3R) inverse agonist in clinical development for the treatment of narcolepsy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105425"}}